Evaluation of efficacy and safety of lascufloxacin for nursing and healthcare associated pneumonia: single-arm, open-label clinical trial: A study protocol.

Naoki Hosogaya,Takahiro Takazono,Kenji Ota,Rieko Kiya,Yumi Shirai,Rina Kawasaki,Hiroshi Yano,Shinpei Morimoto, Rumiko Nakao, Yumiko Kanamaru, Yukari Yoshino,Yasuyuki Ishikawa,Chizu Fukushima,Hiroshi Yamamoto,Koichi Izumikawa,Katsunori Yanagihara,Hiroshi Mukae

Medicine（2023）

引用 0|浏览10

暂无评分

摘要

NHCAP is a common pneumonia in clinical settings and a notable pneumonia whose mortality is high compared to community-acquired pneumonia. The present study showed the efficacy and safety of LSFX against NHCAP, which could lead to a larger number of therapeutic options for NHCAP.

查看译文

关键词

lascufloxacin,healthcare associated pneumonia,nursing,clinical,single-arm,open-label

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要